Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Coronary Artery Diseases (CADs)
4.2.2 Rising of the Geriatric Population
4.2.3 Technological Advancements in Coronary Stents
4.3 Market Restraints
4.3.1 High Product Recalls
4.3.2 Stringent Approval Process for Stents
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION MARKET SEGMENTATION (Market Size by Value – by USD million)
5.1 By Product Type
5.1.1 Drug Eluting Stent
5.1.2 Bare Metal Coronary Stent
5.1.3 Bioabsorbable Stent
5.2 By Biomaterial
5.2.1 Metallic Biomaterial
5.2.2 Polymeric Biomaterial
5.2.3 Natural Biomaterial
5.3 By End User
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Centers
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 B. Braun Melsungen AG
6.1.3 Biosensors International Group Ltd
6.1.4 BIOTRONIK SE & Co. KG
6.1.5 Boston Scientific Corporation
6.1.6 Cook Group
6.1.7 Medtronic PLC
6.1.8 Terumo Corporation
6.1.9 Translumina GmbH
6.1.10 Sahajanand Medical Technologies Limited
6.1.11 Lepu Medical Technology(Beijing)Co.,Ltd.
6.1.12 Bilakhia Holdings Pvt Ltd. (Meril Life Sciences)


7 MARKET OPPORTUNITIES AND FUTURE TRENDS